Recent reports showed that BNP/NT-proBNP-guided treatment can improve clinical outcomes and reduce the hospital stays of patients with CHF, leading to more cost-effective management of the condition6, 7, 24–26. The gene discussed is NPPB; the disease is congestive heart failure.